Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie L Pugh

Showing results (21-30 of 106) with videos related to

Pageof 11
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 19, 2013
RTOG 0631 Phase II/III Study of Image-Guided Stereotactic Radiosurgery for Localized (1-3) Spine Metastases: Phase II ResultsSamuel Ryu, Stephanie L Pugh, Peter C Gerszten, et al.
International Journal of Radiation Oncology, Biology, Physics|April 3, 2015
Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513David G Brachman, Stephanie L Pugh, Lynn S Ashby, et al.
JAMA|April 3, 2014
Tadalafil for prevention of erectile dysfunction after radiotherapy for prostate cancer: the Radiation Therapy Oncology Group [0831] randomized clinical trialThomas M Pisansky, Stephanie L Pugh, Richard E Greenberg, et al.
International Journal of Radiation Oncology, Biology, Physics|February 10, 2021
Psychological Treatment for Patients Receiving Radiation: Results of NRG Oncology/RTOG 0841William Small, Stephanie L Pugh, Lynne I Wagner, et al.
Practical Radiation Oncology|June 4, 2014
RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 resultsSamuel Ryu, Stephanie L Pugh, Peter C Gerszten, et al.
The Journal of Sexual Medicine|June 10, 2024
NRG-CC004 ancillary data study-exploring the effect of bupropion on sexual desire in female cancer survivors with and without vulvovaginal symptomsJeanne Carter, Stephanie L Pugh, Noel Arring, et al.
Head & Neck|August 23, 2019
Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology StudyRonald C Eldridge, Stephanie L Pugh, Andy Trotti, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2018
First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Nonmetastatic Prostate Cancer After Radical ProstatectomyRichard K Valicenti, Stephanie L Pugh, Edouard J Trabulsi, et al.
Journal of the National Cancer Institute|May 22, 2016
Institutional Enrollment and Survival Among NSCLC Patients Receiving Chemoradiation: NRG Oncology Radiation Therapy Oncology Group (RTOG) 0617Bree R Eaton, Stephanie L Pugh, Jeffrey D Bradley, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 5, 2014
The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trialKaren E Hoffman, Stephanie L Pugh, Jennifer L James, et al.
Pageof 11

Showing results (21-30 of 106) with videos related to

Sort By:
Pageof 11
International Journal of Radiation Oncology, Biology, Physics|July 19, 2013
RTOG 0631 Phase II/III Study of Image-Guided Stereotactic Radiosurgery for Localized (1-3) Spine Metastases: Phase II ResultsSamuel Ryu, Stephanie L Pugh, Peter C Gerszten, et al.
International Journal of Radiation Oncology, Biology, Physics|April 3, 2015
Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513David G Brachman, Stephanie L Pugh, Lynn S Ashby, et al.
JAMA|April 3, 2014
Tadalafil for prevention of erectile dysfunction after radiotherapy for prostate cancer: the Radiation Therapy Oncology Group [0831] randomized clinical trialThomas M Pisansky, Stephanie L Pugh, Richard E Greenberg, et al.
International Journal of Radiation Oncology, Biology, Physics|February 10, 2021
Psychological Treatment for Patients Receiving Radiation: Results of NRG Oncology/RTOG 0841William Small, Stephanie L Pugh, Lynne I Wagner, et al.
Practical Radiation Oncology|June 4, 2014
RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 resultsSamuel Ryu, Stephanie L Pugh, Peter C Gerszten, et al.
The Journal of Sexual Medicine|June 10, 2024
NRG-CC004 ancillary data study-exploring the effect of bupropion on sexual desire in female cancer survivors with and without vulvovaginal symptomsJeanne Carter, Stephanie L Pugh, Noel Arring, et al.
Head & Neck|August 23, 2019
Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology StudyRonald C Eldridge, Stephanie L Pugh, Andy Trotti, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2018
First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Nonmetastatic Prostate Cancer After Radical ProstatectomyRichard K Valicenti, Stephanie L Pugh, Edouard J Trabulsi, et al.
Journal of the National Cancer Institute|May 22, 2016
Institutional Enrollment and Survival Among NSCLC Patients Receiving Chemoradiation: NRG Oncology Radiation Therapy Oncology Group (RTOG) 0617Bree R Eaton, Stephanie L Pugh, Jeffrey D Bradley, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 5, 2014
The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trialKaren E Hoffman, Stephanie L Pugh, Jennifer L James, et al.
Pageof 11